pubrio
Asymchem logo

Asymchem

Public
asymchem.com
製藥產業700+ employeesFounded 1999🇨🇳 中國

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

成立年份
1999
員工
700+
行業
製藥產業
公司類型
Public Company
股票
sse: 06821.HK
總部
🇨🇳6 Dongting 3rd Avenue, Teda, Tianjin Municipality, Cn, 300457 (+9)
專長
製藥產業生物技術化學製造
2 / 3
活躍市場
0
新市場
信心度
大多為早期訊號
+1000%
動能
對比上一週期
33 / 100
擴張評分
發展中
階段3投入中
12 個訊號 · 過去 90 日

全球擴張

即時
USGBIN
階段
探索中投入中進入中營運中

活動脈搏

全新 市場推廣與公關 活動 — 剛出現 11 個新訊號。

過去 90 日
招聘
1已結束
招聘
市場推廣與公關
11新增
廣告
產品與技術
0
無活動
+2個類別已鎖定
已顯示 5 個中的 3 個

市場進入時間軸

此公司進入各市場的次序 — 由最舊至最新

1
🇺🇸US第 1st 個進入的市場 · 2012推進中
投入中
16 個訊號投入中 階段
2
🇬🇧GB第 2nd 個進入的市場 · 2024推進中
投入中
14 個訊號投入中 階段
3
🇮🇳IN第 3rd 個進入的市場 · 2025推進中
投入中
1 個訊號投入中 階段
目前階段投入中投入資源
信心度33%
開始追蹤於2012首個訊號

近期訊號

廣告🇵🇹 PT4星期前

Asymchem Basel Symposium

廣告🇺🇸 US4星期前

Asymchem Basel Symposium

註冊以查看完整訊號動態

值得了解

關於 Asymchem 的常見問題

關於 Asymchem 業務、市場及增長訊號的快速解答。

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world's top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we've built a knowledge and experience base that we're ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials' manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem's proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

立即展開你的旅程

可以先用平台,也可以先聊聊

自行使用 Pubrio,或讓我們的團隊協助研究、挖掘潛在客戶,甚至串接資料。

Start Journey Image
pubrio

Pubrio 將 50+ 個在地來源的商業、人才與意圖數據全球化整合,讓 AI 與營收團隊掌握完整市場視野。

© 2026 Pubrio。版權所有。